GRI Bio, Inc.
GRI
$1.46
-$0.05-3.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.20% | 5.69% | -19.24% | 5.84% | 6.22% |
| Total Depreciation and Amortization | -10,400.00% | 107.69% | -186.67% | 139.47% | -195.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 331.91% | 151.65% | -360.00% | 131.53% | -143.53% |
| Change in Net Operating Assets | 47.94% | -191.08% | 158.20% | 89.26% | -741.62% |
| Cash from Operations | 11.86% | -5.93% | 2.81% | 60.38% | -324.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 131.23% | -79.27% | -9.82% | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.77% | 34.29% | 45.07% | -126.13% | -- |
| Cash from Financing | 245.08% | -84.99% | -1.85% | 15.62% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.55% | -171.04% | -0.92% | 235.89% | -28.15% |